Penalized learning identifies a cardiomyopathy-associated cytokine pattern
Source check: Source checked. Not independent scientific confirmation.
Finding: A LASSO-selected four-cytokine combination distinguished chronic Chagas cardiomyopathy from rheumatic heart disease in a small cross-sectional clinical study. The represented finding is a cohort-specific multivariable immune-profile association, not a verified causal inflammatory pathway or a deployable diagnostic test.
Technology: LASSO-regularized logistic learning
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Regularized fitted classification selects a joint cytokine pattern from measured clinical variables; the scoped finding concerns its observed disease-group association.
- Test and result
- The study included 38 chronic Chagas cardiomyopathy cases, 17 rheumatic heart disease cases and 12 healthy controls. An 80:20 random split was described for LASSO logistic classification; the selected panel comprised IL-12p70, IL-7, IL-1Ra and IL-4.
- Limitation / still unknown
- A claimed 100% separation comes from a very small selected sample; the main result does not establish precision, external generalization or a robust future-patient operating threshold. Disease groups have different sex distributions, and controls were much younger. Parameter-selection nesting and test counts are incompletely specified. Conventional pairwise cytokine differences, generic networks and t-SNE visualization are separate from the enabling penalized model. No pathogen experimentation or therapeutic intervention is represented.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8546740/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Exact primary front and selected computational/clinical Methods and corresponding high-level Results; operational laboratory protocols excluded from review.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 1/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.